Michael Pham, M.D., M.P.H.

Publications

• Forecasting the impact of heart failure in the United States: a policy statement from the american heart association. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, Nichol G, Pham M, Piña IL, Trogdon JG. Circ Heart Fail. 2013; 6 (3): 606-19
• Changing trends in infectious disease in heart transplantation. Haddad F, Deuse T, Pham M, Khazanie P, Rosso F, Luikart H, Valantine H, Leon S, Vu TA, Hunt SA, Oyer P, Montoya JG. J Heart Lung Transplant. 2010; 29 (3): 306-15
• Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs health care system 2002 to 2006. Heidenreich PA, Sahay A, Kapoor JR, Pham MX, Massie B. J Am Coll Cardiol. 2010; 56 (5): 362-8
• Gene-expression profiling for rejection surveillance after cardiac transplantation. Pham MX, Teuteberg JJ, Kfoury AG, Starling RC, Deng MC, Cappola TP, Kao A, Anderson AS, Cotts WG, Ewald GA, Baran DA, Bogaev RC, Elashoff B, Baron H, Yee J, Valantine HA. N Engl J Med. 2010; 362 (20): 1890-900
• Right ventricular dysfunction predicts poor outcome following hemodynamically compromising rejection. Haddad F, Fisher P, Pham M, Berry G, Weisshaar D, Kuppahally S, Vrtovec B, Deuse T, Virani S, Fearon W, Valantine H, Hunt S. J Heart Lung Transplant. 2009; 28 (4): 312-9
• Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation. Sinha SS, Pham MX, Vagelos RH, Perlroth MG, Hunt SA, Lee DP, Valantine HA, Yeung AC, Fearon WF. Am Heart J. 2008; 155 (5): 889.e1-6
• Twenty-year survivors of heart transplantation at Stanford University. Deuse T, Haddad F, Pham M, Hunt S, Valantine H, Bates MJ, Mallidi HR, Oyer PE, Robbins RC, Reitz BA. Am J Transplant. 2008; 8 (9): 1769-74
• Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial. Pham MX, Deng MC, Kfoury AG, Teuteberg JJ, Starling RC, Valantine H. J Heart Lung Transplant. 2007; 26 (8): 808-14
• Molecular testing in the management of cardiac transplant recipients: initial clinical experience. Starling RC, Pham M, Valantine H, Miller L, Eisen H, Rodriguez ER, Taylor DO, Yamani MH, Kobashigawa J, McCurry K, Marboe C, Mehra MR, Zuckerman A, Deng MC. J Heart Lung Transplant. 2006; 25 (12): 1389-95
• Prognostic value of electrocardiographic criteria for left ventricular hypertrophy. Hsieh BP, Pham MX, Froelicher VF. Am Heart J. 2005; 150 (1): 161-7
• Cardiac xenotransplantation. Pham MX, Hunt SA, Johnson FL. Coron Artery Dis. 2004; 15 (2): 99-105
• Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes. Pham MX, Whooley MA, Evans GT, Liu C, Emadi H, Tong W, Murphy MC, Fleischmann KE. Am Heart J. 2004; 148 (5): 776-82